Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (141-150 of 281) with videos related to

Pageof 29
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2014
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer modelPatricia Alamo, Alberto Gallardo, Federica Di Nicolantonio, et al.
Science Translational Medicine|February 28, 2020
High-dose vitamin C enhances cancer immunotherapyAlessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
Cancer Research|July 23, 2003
Identifying tumor origin using a gene expression-based classification mapPhillip Buckhaults, Zhen Zhang, Yu-Chi Chen, et al.
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.
Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.
BMC Cancer|September 27, 2014
Mutational profiling of kinases in glioblastomaFonnet E Bleeker, Simona Lamba, Carlo Zanon, et al.
Frontiers in Oncology|February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patientErica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
JCO Precision Oncology|July 30, 2021
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived OrganoidsGianluca Mauri, Erika Durinikova, Alessio Amatu, et al.
Pageof 29

Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 1, 2014
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer modelPatricia Alamo, Alberto Gallardo, Federica Di Nicolantonio, et al.
Science Translational Medicine|February 28, 2020
High-dose vitamin C enhances cancer immunotherapyAlessandro Magrì, Giovanni Germano, Annalisa Lorenzato, et al.
Human Mutation|May 23, 2009
Molecular profiling of the "plexinome" in melanoma and pancreatic cancerAsha Balakrishnan, Junia Y Penachioni, Simona Lamba, et al.
Cancers|January 11, 2022
Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver MetastasesValentina Giannini, Laura Pusceddu, Arianna Defeudis, et al.
Cancer Research|July 23, 2003
Identifying tumor origin using a gene expression-based classification mapPhillip Buckhaults, Zhen Zhang, Yu-Chi Chen, et al.
ESMO Open|February 2, 2018
Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical caseErika Martinelli, Teresa Troiani, Vincenzo Sforza, et al.
Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.
BMC Cancer|September 27, 2014
Mutational profiling of kinases in glioblastomaFonnet E Bleeker, Simona Lamba, Carlo Zanon, et al.
Frontiers in Oncology|February 23, 2023
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patientErica Torchiaro, Consalvo Petti, Sabrina Arena, et al.
JCO Precision Oncology|July 30, 2021
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived OrganoidsGianluca Mauri, Erika Durinikova, Alessio Amatu, et al.
Pageof 29